Signs and Symptoms of Serotonin Syndrome
Serotonin syndrome presents with a characteristic clinical triad: mental status changes, autonomic hyperactivity, and neuromuscular abnormalities, typically developing within 6-24 hours of starting, increasing, or combining serotonergic medications like SSRIs. 1
Core Clinical Triad
Mental Status Changes
- Agitated delirium is the most common mental status alteration 1
- Confusion and disorientation occur frequently 1, 2
- Altered consciousness ranging from mild confusion to coma in severe cases 1
- Restlessness that feels uncontrollable 3
- Severe agitation or anxiety 3
Neuromuscular Abnormalities (Most Diagnostic Features)
- Clonus and hyperreflexia are highly diagnostic when occurring with serotonergic drug use 1
- Myoclonus (muscle twitching) occurs in 57% of cases and is the most common finding 3
- Spontaneous clonus, inducible clonus, or ocular clonus 1
- Hyperreflexia (exaggerated reflexes) 1, 3
- Muscle rigidity or stiffness, especially in lower extremities 1, 3
- Tremor 1, 2
- Ataxia (loss of coordination) 2
Autonomic Hyperactivity
- Elevated temperature up to 41.1°C (106°F) 1
- Tachycardia (rapid heart rate) 1, 3
- Tachypnea (rapid breathing) 1, 3
- Hypertension or blood pressure fluctuations (≥20 mm Hg diastolic or ≥25 mm Hg systolic change within 24 hours) 1
- Profuse diaphoresis (sweating) 1, 3
- Mydriasis (dilated pupils) 1
- Shivering 3
- Vomiting or diarrhea 3, 2
Critical Timing
Symptoms typically emerge within minutes to hours (usually 6-24 hours) after starting or increasing the dose of a serotonergic medication or adding a second serotonergic agent, making this the highest-risk monitoring window. 1, 3
The condition is non-idiosyncratic, meaning it can occur predictably with the addition of a new drug, increased dosage of an existing drug, or addition of a second serotonergic drug 1
Severity Spectrum
Mild to Moderate Cases
- Present with the clinical triad but without life-threatening complications 1
- Most cases resolve within 24-48 hours after discontinuing serotonergic agents and initiating supportive care 1
Severe Cases (Medical Emergency)
- Rapid onset of severe hyperthermia (>41.1°C) 1
- Severe muscle rigidity 1
- Multiple organ failure 1
- Seizures 3
- Loss of consciousness 3
Life-Threatening Complications
- Rhabdomyolysis with elevated creatine kinase 1
- Metabolic acidosis 1
- Elevated serum aminotransferase 1
- Renal failure with elevated serum creatinine 1
- Disseminated intravascular coagulopathy 1
- The mortality rate is approximately 11% 1, 3
Diagnostic Considerations
The Hunter Criteria have higher sensitivity (84%) and specificity (97%) for diagnosis and require the presence of one of the following after taking a serotonergic agent: 1
- Spontaneous clonus
- Inducible clonus with agitation or diaphoresis
- Ocular clonus with agitation or diaphoresis
- Tremor and hyperreflexia
- Hypertonia, temperature above 38°C, and ocular or inducible clonus
There are no pathognomonic laboratory or radiographic findings for serotonin syndrome 1
Common Clinical Pitfalls
The presentation is extremely variable, and mild cases may be easily missed 1
Patients often fail to report over-the-counter medications (like dextromethorphan), herbal supplements (like St. John's Wort), or recreational drugs (like MDMA) that can contribute to serotonin syndrome 4, 3
High-Risk Populations
Patients taking SSRIs (fluoxetine, sertraline, paroxetine, citalopram, escitalopram, fluvoxamine) are at risk, with fluvoxamine showing the highest risk among SSRIs 4
The most dangerous combinations involve MAOIs with any other serotonergic drug, which are involved in most severe and fatal cases 4, 3